Rice Hall James & Associates LLC cut its holdings in Medidata Solutions Inc (NASDAQ:MDSO) by 5.0% in the second quarter, HoldingsChannel reports. The firm owned 392,849 shares of the company’s stock after selling 20,875 shares during the period. Medidata Solutions accounts for approximately 1.2% of Rice Hall James & Associates LLC’s portfolio, making the stock its 20th biggest holding. Rice Hall James & Associates LLC’s holdings in Medidata Solutions were worth $35,557,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of the stock. ARP Americas LP acquired a new position in shares of Medidata Solutions during the second quarter valued at about $35,960,000. Syquant Capital Sas bought a new stake in shares of Medidata Solutions during the second quarter valued at approximately $31,293,000. BlackRock Inc. grew its stake in shares of Medidata Solutions by 4.3% during the first quarter. BlackRock Inc. now owns 7,293,413 shares of the company’s stock valued at $534,167,000 after purchasing an additional 297,812 shares during the last quarter. Nikko Asset Management Americas Inc. grew its stake in shares of Medidata Solutions by 16.8% during the first quarter. Nikko Asset Management Americas Inc. now owns 1,259,943 shares of the company’s stock valued at $92,278,000 after purchasing an additional 181,553 shares during the last quarter. Finally, ARK Investment Management LLC grew its stake in shares of Medidata Solutions by 19.4% during the first quarter. ARK Investment Management LLC now owns 1,117,845 shares of the company’s stock valued at $81,871,000 after purchasing an additional 181,286 shares during the last quarter. Hedge funds and other institutional investors own 96.04% of the company’s stock.
MDSO stock traded up $0.05 during midday trading on Wednesday, reaching $91.39. The company’s stock had a trading volume of 334,286 shares, compared to its average volume of 1,014,589. Medidata Solutions Inc has a 52 week low of $60.10 and a 52 week high of $98.60. The stock has a market capitalization of $5.71 billion, a PE ratio of 95.19, a PEG ratio of 6.04 and a beta of 1.23. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.56 and a current ratio of 2.56. The stock’s 50-day moving average price is $90.98.
Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Monday, July 22nd. The company reported $0.48 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.17 by $0.31. The company had revenue of $180.50 million for the quarter, compared to analyst estimates of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The business’s revenue for the quarter was up 15.8% compared to the same quarter last year. During the same period last year, the business posted $0.43 earnings per share. Analysts predict that Medidata Solutions Inc will post 0.8 earnings per share for the current year.
A number of brokerages have issued reports on MDSO. BidaskClub raised shares of Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 7th. Guggenheim cut shares of Medidata Solutions from a “buy” rating to a “neutral” rating and set a $92.25 price objective on the stock. in a research note on Wednesday, June 12th. SunTrust Banks raised their price objective on shares of Medidata Solutions from $85.00 to $92.25 and gave the company a “hold” rating in a research note on Thursday, June 13th. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. Finally, William Blair cut shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 12th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $84.27.
In other Medidata Solutions news, Director Robert Taylor sold 3,294 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $90.88, for a total value of $299,358.72. Following the sale, the director now directly owns 41,757 shares in the company, valued at $3,794,876.16. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 4.70% of the company’s stock.
Medidata Solutions Company Profile
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Recommended Story: G-20
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.